Develops high value proteins and oil body based products for personal care, nutrition and pharmaceutical industries using its proprietary oil body/oleosin technology. SemBioSys completed an Initial Public Offering in December 2004 (TSX:SBS).
SemBioSys Genetics
![SemBioSys Genetics](http://baycitycapital.com/wp-content/uploads/2014/04/portfolio-sembiosys.jpg)